Physicians' Academy for Cardiovascular Education

SGLT2 inhibition: What are the potential mechanisms for clinical benefit?

May 13, 2016

Presentation prepared and held by Prof Hiddo Lambers Heerspink, MD, University Medical Centre Groningen, The Netherlands at the CME accredited 'Asian Cardio Diabetes Forum' held on April 23-24, 2016 in Kuala Lumpur, Malaysia.

The presentation is provided as an educational service to registered members only
 

Download as PDF

SGLT2 inhibition. What are the potential mechanisms of benefit. prof Lambers Heerspink.pdf (1,5MB)SGLT2 inhibition. What are the potential mechanisms of benefit. prof Lambers Heerspink.pdf (1,5MB)

View slides, click on images